Abstract
The period 2008-2023 will see a vaccine “boost”. There will be a
new resurgence in the sales and utilisation of vaccines. Are you prepared for
this? You should be.
During this period, vaccines will be one of the fastest growing segments of
the pharmaceutical market. Vaccine revenues will increase in size by several
hundred percent between 2007 and 2023. This brand new in-depth report The
Global Vaccines Market, 2008-2023 describes trends in the market both
quantitatively and qualitatively. In recent years, this global vaccines market
has undergone a renaissance, as the importance of vaccines in both developed
and developing nations becomes underlined by epidemiological patterns and
healthcare needs.
The key growth driver for vaccines is their cost-effectiveness in combating
disease. This situation will encourage greater use of vaccines by governments
and private healthcare providers. New disease targets that could be mitigated
through vaccination, including high profile (and potentially profitable)
targets such as cancer. Visiongain notes that many healthcare providers are
viewing preventative medicine enthusiastically, being aware of the significant
increases in quality of life and reduction of healthcare expenditure that can
result from prophylaxis. The vaccines industry is responding with innovative
products, making full use of technological advances in biotechnology. This
market has great developmental potential, both therapeutically and
commercially. There are currently more than 1000 vaccines in research and
development worldwide.
In particular, The Global Vaccines Market, 2008-2023 concentrates on the following essential aspects of the vaccine industry:
- Sales forecasts for vaccines by disease area, brand and country, including
novel therapeutic vaccines
- Examination of strengths, weakness, opportunities and threats facing the
vaccine industry
- Expert opinion from key-opinion leaders in the field
- In-depth analysis of the vaccine pipeline
- Analysis of the prospects for therapeutic vaccines
- Geographical breakdown of the vaccine market, including the leading
emerging markets of China and India
- Coverage of future trends in vaccine technology, formulation and
manufacturing
- Identification of key industrial players in the vaccines market.
The Global Vaccines Market, 2008-2023 examines the vaccines market
comprehensively, using unique primary and secondary research. The report
includes full transcripts of interview - you cannot get this information
anywhere else.
Also included are company reports, filings and industry databases.
Exclusively, visiongain have applied their in-house analytical techniques for
financial forecasting and analysis of drivers and restraints. Now available to
you this comprehensive market-based report with detailed analyses, forecasts
and informed opinion is essential to your vaccine market development.
Therapeutic vaccines differ from currently-marketed vaccines. Instead of
simply preventing infection from disease, therapeutic vaccines work with the
body' s immune system to fight diseases and disorders, including cancer,
addiction and allergies. Their therapeutic and commercial potential is vast.
Visiongain predicts that therapeutic vaccines will significantly expand the
market for vaccines, contributing to rapid revenue growth during the period
2008 to 2023.
Why you should buy this report:
- To receive a comprehensive analysis of the prospects for vaccines,
including key metrics and predicted revenues, by vaccine disease area and
leading brand
- To receive forecasts of vaccine sales in leading country markets from
2008-2023, including China and India
- To discover the views of experts in the vaccines sector
- To determine the forces that influence the market for vaccines: drivers,
restraints, opportunities and threats
- To find out where the vaccines market is heading - both technologically
and commercially from 2008 to 2023.
| 
View Cart
